2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole
Structure Info
- Chemspace ID
- CSSB00120463441 (In-Stock Building Blocks)
- IUPAC Name
- 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole
- Mol formula
- C13H19BN4O2S
- Mol weight
- 306 Da
- Catalog Number(s)
- BBLS00120463441, BBV-151359425, CSC120463441, EN300-54900740, bbls00120463441
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.51
- Heavy atoms count
- 21
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.615
- Polar surface area (Å)
- 62
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
![Chemical structure of 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole (C13H19BN4O2S) - CSSB00120463441](/st/structure/200/e687f30b291fbc37d0b492886b2d79c1/CC1%253DNN%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png "C13H19BN4O2S")
- Zoom the structure
- CSSB00120463441
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 1,009.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 1,056.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,104.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,152.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,200.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,351.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,479.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 5,159.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 2-cyclopropyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole - CSSB02161347693](/st/structure/200/05efdcff444ed3542cfcf54a6e03b083/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DNN%253DC%2528S2%2529C2CC2%2529N%253DC1.png)
Similarity Analogs
![Chemical structure of 2,5-dimethyl-4-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB00125100402](/st/structure/200/f71415b8732d9ad81874be47938ba36d/CC1%253DNC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DC%2528C%2529S1.png)
![Chemical structure of 4,5-dimethyl-2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB00125099171](/st/structure/200/6e62cd01b9958728318788546d3bc921/CC1%253DC%2528C%2529N%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png)
![Chemical structure of 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-thiazole - CSSB00055493053](/st/structure/200/bcd10f5414def067bf27bc327e5740d7/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DCN%253DCS2%2529N%253DC1.png)
![Chemical structure of 3-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2,4-thiadiazole - CSSB00156650914](/st/structure/200/d5046f8016544928d2cf4c17ddc5b37e/CC1%253DNSC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DN1.png)
![Chemical structure of 2-[(4-methoxy-1H-pyrazol-1-yl)methyl]-5-methyl-1,3,4-thiadiazole - CSSB00155449138](/st/structure/200/17709ab73b108986b29920894236a66f/COC1%253DCN%2528CC2%253DNN%253DC%2528C%2529S2%2529N%253DC1.png)
![Chemical structure of 5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,2,4-thiadiazole - CSSB20551580496](/st/structure/200/cd97a1b65000fc789a8cdfc25195e8a5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DNC%253DNS2%2529N%253DC1.png)
